Pages that link to "Item:Q4855194"
From MaRDI portal
The following pages link to Bivariate Sequential Designs for Phase II Trials (Q4855194):
Displaying 12 items.
- On the maximum total sample size of a group sequential test about bivariate binomial propor\-tions (Q544640) (← links)
- Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials (Q1727847) (← links)
- Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials (Q2059113) (← links)
- A curtailed procedure for selecting among treatments with two Bernoulli endpoints (Q2135601) (← links)
- Some geometric methods for constructing decision criteria based on two-dimensional parame\-ters (Q2475737) (← links)
- Monitoring the Rates of Composite Events with Censored Data in Phase II Clinical Trials (Q3078908) (← links)
- Testing Statistical Hypotheses on Stochastic Ordering of Discrete Distributions (Q3094211) (← links)
- MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (Q4512728) (← links)
- Treatment Comparisons Based on Two‐Dimensional Safety and Efficacy Alternatives in Oncology Trials (Q4666639) (← links)
- Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes (Q4666685) (← links)
- A Bayesian Group Sequential Approach for Multiple Endpoints (Q4678861) (← links)
- Two-stage phase II trials with early stopping for effectiveness and safety as well as ineffectiveness or harm (Q5076974) (← links)
